28 Results for "

p38γ

" in MedChemExpress (MCE) Product Catalog:
Products (28)

28 Results for "p38γ" in MCE Product Catalog:

  • Isoforms Recommended:
52
52 Publications Verification
Cat. No.: HY-10320
CAS No.: 285983-48-4
Purity:  99.76%
Synonyms: BIRB 796
Target:  

p38 MAPK Raf Autophagy

Research Areas:  

Inflammation/Immunology Cancer

Doramapimod (BIRB 796) is an orally active, highly potent p38 MAPK inhibitor, which has an IC50 for p38α=38 nM, for p38β=65 nM, for p38γ=200 nM, and for p38δ=520 nM. Doramapimod has picomolar affinity for p38 kinase (Kd=0.1 nM). Doramapimod also inhibits B-Raf with an IC50 of 83 nM .
loading...
    loading...
31
31 Cited Publications
Cat. No.: HY-11068
CAS No.: 193551-21-2
Purity:  99.15%
SB 239063 is a potent, selective and orally active p38 MAPK inhibitor, exhibits an IC50 of 44 nM for recombinant purified human p38α, with equipotent inhibitory activity against p38α and p38β. SB 239063 has no effect on p38γ or p38δ. With anti-asthma activity and also be used to enhance memory which is impaired due to aging or medical conditions, such as, AD. SB 239063 can penetrate the blood brain barrier (BBB) .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-10405
CAS No.: 449811-01-2
Purity:  99.92%
Synonyms: Ro4402257; R1503
Target:  

p38 MAPK Autophagy

Research Areas:  

Inflammation/Immunology

Pamapimod (Ro4402257) is a potent, selective and orally active p38 MAPK inhibitor with IC50s of 14 nM and 480 nM and Kis of 1.3 nM and 120 nM for p38α and p38β, respectively. Pamapimod has no activity against p38δ or p38γ isoforms. Pamapimod has the potential for rheumatoid arthritis and other autoimmune diseases treatment .
loading...
    loading...
Cat. No.: HY-108642
CAS No.: 864249-60-5
Purity:  98.28%
Target:  

p38 MAPK Casein Kinase

Research Areas:  

Inflammation/Immunology

AMG-548, an orally active and selective p38α inhibitor (Ki=0.5 nM), shows slightly selective over p38β (Ki=36 nM) and >1000 fold selective against p38γ and p38δ. AMG 548 is also extremely potent in the inhibition of whole blood LPS stimulated TNFα (IC50=3 nM) . AMG-548 inhibits Wnt signaling by directly inhibiting Casein kinase 1 isoforms δ and ε .
loading...
    loading...
Cat. No.: HY-108642B
CAS No.: 2518299-32-4
Purity:  99.86%
Target:  

p38 MAPK Casein Kinase

Research Areas:  

Inflammation/Immunology

AMG-548 dihydrochloride, an orally active and selective p38α inhibitor (Ki=0.5 nM), shows slightly selective over p38β (Ki=36 nM) and >1000 fold selective against p38γ and p38δ. AMG-548 dihydrochloride is also extremely potent in the inhibition of whole blood LPS stimulated TNFα (IC50=3 nM) . AMG-548 dihydrochloride inhibits Wnt signaling by directly inhibiting Casein kinase 1 isoforms δ and ε .
loading...
    loading...
Cat. No.: HY-15505
CAS No.: 215303-72-3
Purity:  99.75%
Synonyms: JNJ 3026582
RWJ-67657 (JNJ 3026582) is an orally active and selective p38α and p38β MAPK inhibitor with IC50s of 1 and 11 μM, respectively. RWJ-67657 displays no activity at p38γ and p38δ, and exhibits cardio protective effect. Anti-inflammatory and anti-tumor activity .
loading...
    loading...
Cat. No.: HY-170879
CAS No.: 696629-98-8
Target:  

p38 MAPK JNK

Research Areas:  

Cancer

JD123 inhibits JNK1 activity and the expression of cJun (1-135). JD123 is a ATP-competitive p38-γ MAPK inhibitor, but not effect to ERK1, ERK2, or p38-α, p38-β or p38-δ. .
loading...
    loading...
Cat. No.: HY-114405
CAS No.: 2254609-23-7
Target:  

PROTACs p38 MAPK Autophagy

Research Areas:  

Cancer

SJFδ is a 10-atom linker PROTAC based on von Hippel-Lindau ligand. SJFδ degrades p38δ with a DC50 of 46.17 nM, but does not degrade p38α, p38β, or p38γ .
loading...
    loading...
Cat. No.: HY-155377
CAS No.: 2418614-81-8
Research Areas:  

Cancer

PLK1/p38γ-IN-1(compound 14) is a multitarget inhibitors ofPLK1andp38γ. PLK1/p38γ-IN-1inhibits the growth of human hepatocellular carcinoma and hepatoblastoma cells in vitro .
loading...
    loading...
Cat. No.: HY-10320G
CAS No.: 285983-48-4
Synonyms: BIRB 796 (GMP)
Target:  

p38 MAPK

Research Areas:  

Cancer

Doramapimod GMP (BIRB 796 GMP) is an orally active inhibitor for p38 MAPK, with IC50s of 38, 65, 200 and 520 nM, for p38α, p38β, p38γ, p38δ. Doramapimod exhibits cytotoxicity and antitumor activity against multiple myeloma, synergizes with multidrug resistance protein 1 (ABCB1) and aurora kinase inhibitor VX680, promoting their antitumor efficacy against oral epidermoid carcinoma and cervical cancer. Doramapimod also exhibits anti-inflammatory activity .
loading...
    loading...
Cat. No.: HY-14412
CAS No.: 1262406-08-5
Target:  

p38 MAPK

Research Areas:  

Cancer

p38α inhibitor 4 (compound 10) is a selective and allosteric p38α inhibitor with an IC50 value of 1.2 μM. p38α inhibitor 4 exhibits no activity against p38β, p38γ, and p38δ .
loading...
    loading...
Cat. No.: HY-147518
CAS No.: 1443242-46-3
Target:  

p38 MAPK

Research Areas:  

Inflammation/Immunology

p38-α MAPK-IN-5 (compound 4e) is a potent p38α inhibitor with IC50s of 0.1 nM, 0.2 nM, 944 nM, 4100 nM for p38α, p38 β, p38γ, p38δ, respectively. p38-α MAPK-IN-5 has anti-inflammatory effect. p38-α MAPK-IN-5 has the potential for asthma and chronic obstructive pulmonary disease (COPD) research .
loading...
    loading...
Cat. No.: HY-10320R
CAS No.: 285983-48-4
Synonyms: BIRB 796 (Standard)
Doramapimod (Standard) is the analytical standard of Doramapimod. This product is intended for research and analytical applications. Doramapimod (BIRB 796) is an orally active, highly potent p38 MAPK inhibitor, which has an IC50 for p38α=38 nM, for p38β=65 nM, for p38γ=200 nM, and for p38δ=520 nM. Doramapimod has picomolar affinity for p38 kinase (Kd=0.1 nM). Doramapimod also inhibits B-Raf with an IC50 of 83 nM .
loading...
    loading...
Cat. No.: HY-10405R
CAS No.: 449811-01-2
Synonyms: Ro4402257 (Standard); R1503 (Standard)
Pamapimod (Standard) is the analytical standard of Pamapimod. This product is intended for research and analytical applications. Pamapimod (Ro4402257) is a potent, selective and orally active p38 MAPK inhibitor with IC50s of 14 nM and 480 nM and Kis of 1.3 nM and 120 nM for p38α and p38β, respectively. Pamapimod has no activity against p38δ or p38γ isoforms. Pamapimod has the potential for rheumatoid arthritis and other autoimmune diseases treatment .
loading...
    loading...
Cat. No.: HY-15505R
CAS No.: 215303-72-3
Synonyms: JNJ 3026582 (Standard)
RWJ-67657 (Standard) is the analytical standard of RWJ-67657. This product is intended for research and analytical applications. RWJ-67657 (JNJ 3026582) is an orally active and selective p38α and p38β MAPK inhibitor with IC50s of 1 and 11 μM, respectively. RWJ-67657 displays no activity at p38γ and p38δ, and exhibits cardio protective effect. Anti-inflammatory and anti-tumor activity .
loading...
    loading...
Cat. No.: HY-10405S
CAS No.: 1246814-57-2
Pamapimod-d4 (Ro4402257-d4) is the deuterium labeled Pamapimod. Pamapimod (Ro4402257) is a potent, selective and orally active p38 MAPK inhibitor with IC50s of 14 nM and 480 nM and Kis of 1.3 nM and 120 nM for p38α and p38β, respectively. Pamapimod has no activity against p38δ or p38γ isoforms. Pamapimod has the potential for rheumatoid arthritis and other autoimmune diseases treatment .
loading...
    loading...
Cat. No.: HY-108642A
CAS No.: 2437438-16-7
Target:  

p38 MAPK Casein Kinase

Research Areas:  

Inflammation/Immunology

AMG-548 hydrochloride, an orally active and selective p38α inhibitor (Ki=0.5 nM), shows slightly selective over p38β (Ki=36 nM) and >1000 fold selective against p38γ and p38δ. AMG-548 hydrochloride is also extremely potent in the inhibition of whole blood LPS stimulated TNFα (IC50=3 nM) . AMG-548 hydrochloride inhibits Wnt signaling by directly inhibiting Casein kinase 1 isoforms δ and ε .
loading...
    loading...
Cat. No.: HY-119138
CAS No.: 321344-32-5
Target:  

p38 MAPK MMP PGE synthase

Research Areas:  

Inflammation/Immunology

R-130823 is an orally active, highly selective p38α inhibitor with an IC50 of 22 nM against p38α, an IC50 of 820 nM against p38β, and no activity against p38γ or p38δ. R-130823 downregulates downstream cartilage degradation and inflammatory mediators, and inhibits the release of MMP-13, MMP-1 and PGE2. R-130823 reduces hind paw swelling, improves hyperalgesia, and blocks arthritis progression. R-130823 is applicable to research related to osteoarthritis and rheumatoid arthritis .
loading...
    loading...
Cat. No.: HY-11068R
CAS No.: 193551-21-2
SB 239063 (Standard) is the analytical standard of SB 239063 (HY-11068). This product is intended for research and analytical applications. SB 239063 is a potent, selective and orally active p38 MAPK inhibitor, exhibits an IC50 of 44 nM for recombinant purified human p38α, with equipotent inhibitory activity against p38α and p38β. SB 239063 has no effect on p38γ or p38δ. With anti-asthma activity and also be used to enhance memory which is impaired due to aging or medical conditions, such as, AD. SB 239063 can penetrate the blood brain barrier (BBB) .
loading...
    loading...
Cat. No.: HY-108642BR
CAS No.: 2518299-32-4
AMG-548 dihydrochloride (Standard) is the analytical standard of AMG-548 (dihydrochloride) (HY-108642B). This product is intended for research and analytical applications. AMG-548 dihydrochloride, an orally active and selective p38α inhibitor (Ki=0.5 nM), shows slightly selective over p38β (Ki=36 nM) and >1000 fold selective against p38γ and p38δ. AMG-548 dihydrochloride is also extremely potent in the inhibition of whole blood LPS stimulated TNFα (IC50=3 nM) . AMG-548 dihydrochloride inhibits Wnt signaling by directly inhibiting Casein Kinase 1 isoforms δ and ε .
loading...
    loading...